Nitric oxide-targeted therapy inhibits stemness and increases the efficacy of tamoxifen in estrogen receptor-positive breast cancer cells
Crossref DOI link:
Update policy: https://doi.org/10.1007/springer_crossmark_policy
López-Sánchez, Laura M.
De la Haba-Rodríguez, Juan R.
Text and Data Mining valid from 2020-12-01
Version of Record valid from 2020-12-01
13 February 2020
28 October 2020
29 October 2020
1 December 2020
Compliance with ethical standards
The authors declare that they have no conflict of interest.